July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Expression of nicotinamide N-methyltransferase (NNMT) in atopic cataract
Author Affiliations & Notes
  • Satoshi Iwamoto
    Juntendo Univ School of Med, Chiyodaku, TOKYO, Japan
  • Kanae Kobayashi
    Japanese Red Cross Medical Center, Japan
  • Toshinari Funaki
    Japanese Red Cross Medical Center, Japan
  • Kanji Hori
    Juntendo Univ School of Med, Chiyodaku, TOKYO, Japan
  • Satoru Nakatani
    Juntendo Univ School of Med, Chiyodaku, TOKYO, Japan
  • Akira Matsuda
    Juntendo Univ School of Med, Chiyodaku, TOKYO, Japan
  • Footnotes
    Commercial Relationships   Satoshi Iwamoto, None; Kanae Kobayashi, None; Toshinari Funaki, None; Kanji Hori, None; Satoru Nakatani, None; Akira Matsuda, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 5698. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Satoshi Iwamoto, Kanae Kobayashi, Toshinari Funaki, Kanji Hori, Satoru Nakatani, Akira Matsuda; Expression of nicotinamide N-methyltransferase (NNMT) in atopic cataract. Invest. Ophthalmol. Vis. Sci. 2019;60(9):5698.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Atopic cataract is characterized by the formation of anterior subcapsular cataract. But the mechanism of forming the anterior subcapsular cataract is not clear. To clarify the mechanism of atopic cataract, we performed genome wide gene expression analysis of anterior capsule in atopic cataract from the patients. From the results of gene expression analysis, we focused on the NNMT protein that activate TGFβ and related to the remodeling of tissues.

Methods : Anterior capsules of atopic cataract were obtained at the time of cataract surgeries. Control anterior capsules were obtained from senile cataract patients. Total RNA was obtained from the anterior capsules and genome wide gene expression analysis was carried out using Agilent SurePrint Human Gene Expression array. Quantitative PCR (q-PCR) was carried out using other sets of anterior capsules obtained from atopic cataract patients. We also performed immunohistochemical analysis using an anti-human NNMT antibody.

Results : Genome wide gene expression analysis showed significant increase of NNMT gene expression in atopic cataracts samples compared to control samples. Q-PCR analysis shows higher expression of NNMT in the atopic anterior capsule samples compared to the control. Furthermore, immunohistochemical staining showed positive NNMT staining in the fibrotic region of anterior subcapsular cataracts of the atopic patients.

Conclusions : Hyperexpression of NNMT was observed in the anterior capsule of atopic cataract patients. These results suggest the possible relation between NNMT expression and atopic cataract pathophysiology.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×